Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 2150 of 3173 entries
View as:

Palbociclib Plus Letrozole For Postmenopausal Women With HR(+) HER2(-) Advanced Breast Cancer For Whom Letrozole Is Deemed Appropriate

Phase: N/A Priority: Normal
NCT ID: NCT02600923 Org: User:
Start: 04/15/16 End: 05/28/19 Due: 05/28/20

Time To Efficacy and Onset Of Action Of Linezolid

Phase: N/A Priority: Normal
NCT ID: NCT00147511 Org: User:
Start: 06/30/03 End: 06/30/05 Due: 06/30/06

A First In Human Study In Healthy People To Evaluate Safety, Toleration And Time Course Of Plasma Concentration Of Single Inhaled Doses Of PF-05212372.

Phase: N/A Priority: Normal
NCT ID: NCT01415102 Org: User:
Start: 09/30/10 End: 12/31/10 Due: 12/31/11

A Retrospective Real World Analysis Of Sutent In Patients With Metastatic Renal Cell Carcinoma In Community And Academic Centers To Assess The Impact Of Dose Variation On Duration Of Response And Overall Survival

Phase: N/A Priority: Normal
NCT ID: NCT01917214 Org: User:
Start: 08/31/13 End: 03/31/14 Due: 03/31/15

A Phase 2, Multi-Center Study To Compare The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist With Ranibizumab In Adults With Diabetic Macular Edema

Phase: N/A Priority: Normal
NCT ID: NCT01994291 Org: User:
Start: 11/30/13 End: 08/31/15 Due: 08/31/16

A Study to Learn If the Study Medicine Called Vepdegestrant Changes How the Body Processes the Other Study Medicine Called Midazolam

Phase: N/A Priority: Normal
NCT ID: NCT06256510 Org: User:
Start: 02/08/24 End: 05/13/24 Due: 05/13/25

Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT02092467 Org: User:
Start: 03/14/14 End: 07/22/20 Due: 07/22/21

Lipitor In The Prevention Of Stroke, For Patients Who Have Had A Previous Stroke

Phase: N/A Priority: Normal
NCT ID: NCT00147602 Org: User:
Start: 11/30/98 End: 11/30/05 Due: 11/30/06

First in Human Study for PF-06667272

Phase: N/A Priority: Normal
NCT ID: NCT03126149 Org: User:
Start: 05/11/17 End: 09/05/17 Due: 09/05/18

A Phase 3 Study Comparing 2 Doses Of CP-690,550 And The Active Comparator, Humira (Adalimumab) Vs. Placebo For Treatment Of Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00853385 Org: User:
Start: 05/31/09 End: 03/31/11 Due: 03/31/12

Study Evaluating the Cost of the Treatments of the Refractory Psoriatic Arthritis to the Conventional Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00303186 Org: User:
Start: 02/28/05 End: 06/30/11 Due: 06/30/12

Treatment Patterns and Clinical Outcomes Among Patients With Advanced Renal Cell Carcinoma (aRCC) Receiving Systemic First-line (1st Line) Anti-cancer Treatment Under Daily Routine in Germany: Retrospective Medical Chart Review (RENALISTIC Study).

Phase: N/A Priority: Normal
NCT ID: NCT05534789 Org: User:
Start: 10/15/22 End: 12/13/23 Due: 12/13/24

Effect of Prevnar 13 on Ear Infections in Children

Phase: N/A Priority: Normal
NCT ID: NCT01199016 Org: User:
Start: 09/30/10 End: 01/31/16 Due: 01/31/17

Exubera Large Simple Trial To Evaluate Long-Term Pulmonary And Cardiovascular Safety

Phase: N/A Priority: Normal
NCT ID: NCT00359801 Org: User:
Start: 07/31/06 End: 04/30/09 Due: 04/30/10

Study Of SU011248 Versus Chemotherapy For Patients With Previously Treated Triple Receptor Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00246571 Org: User:
Start: 01/31/06 End: 06/30/11 Due: 06/30/12

A Study to Characterize the Abuse Liability of ALO-02 in Healthy, Non-Dependent, Recreational Opioid Users When ALO-02 Capsules Are Crushed and Snorted

Phase: N/A Priority: Normal
NCT ID: NCT01775189 Org: User:
Start: 02/28/13 End: 07/31/13 Due: 07/31/14

Korea Comirnaty Post-marketing Surveillance

Phase: N/A Priority: Normal
NCT ID: NCT05032976 Org: User:
Start: 03/18/22 End: 03/04/27 Due: 03/04/28

SPECIAL INVESTIGATION FOR ABRYSVO IN PREGNANT WOMEN AND INFANTS

Phase: N/A Priority: Normal
NCT ID: NCT06482099 Org: User:
Start: 10/01/24 End: 09/30/26 Due: 09/30/27

A Study to Evaluate the Efficacy and Safety of Factor IX Gene Therapy With PF-06838435 in Adult Males With Moderately Severe to Severe Hemophilia B

Phase: N/A Priority: Normal
NCT ID: NCT03861273 Org: User:
Start: 07/29/19 End: 02/25/31 Due: 02/25/32

A Study of Ponsegromab in People With Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT05492500 Org: User:
Start: 09/26/22 End: 03/05/25 Due: 03/05/26

Impact and Effectiveness of ABRYSVO® Vaccination During Pregnancy

Phase: N/A Priority: Normal
NCT ID: NCT06647654 Org: User:
Start: 08/26/24 End: 10/01/26 Due: 10/01/27

Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias

Phase: N/A Priority: Normal
NCT ID: NCT00261846 Org: User:
Start: 01/18/06 End: 08/06/15 Due: 08/06/16

Use and Effectiveness of COVID-19 Vaccines Using State Vaccine Registries and Insurance Claims Data

Phase: N/A Priority: Normal
NCT ID: NCT05876377 Org: User:
Start: 10/23/23 End: 12/31/25 Due: 12/31/26

A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2

Phase: N/A Priority: Normal
NCT ID: NCT06072183 Org: User:
Start: 11/08/23 End: 07/30/27 Due: 07/30/28

A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose

Phase: N/A Priority: Normal
NCT ID: NCT06866405 Org: User:
Start: 04/16/25 End: 02/24/28 Due: 02/24/29